“…Alterations in proteins abundance, structure, or function, act as useful indicators of pathological abnormalities prior to development of clinical symptoms and such are often useful diagnostic and prognostic biomarkers (Issaq and Blonder, 2009). Proteomic techniques have been wildly applied to the study of cancer (Kumar et al, 2010;Pietrowska et al, 2009;Vydra et al, 2008), cardiovascular disease (Dardé et al, 2010;Yu et al, 2007), and other diseases (Araki et al, 2011;Cho et al, 2011;Kataria et al, 2011;Pešić et al, 2011;Terracciano et al, 2011). The application of proteomic investigations in the study of prostate cancer has aimed at improving the currently available Prostate-Specific Antigen (PSA) screening test.…”